NCT06727396View on ClinicalTrials.gov

A Study to Investigate the Safety, Tolerability, PK, and PD of CKD-508 in Healthy Participants

PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 14, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions
Healthy Subjects
Interventions
DRUG

CKD-508 Tablet

Investigational drug

DRUG

Placebo Tablet

Placebo

Trial Locations (1)

91206

RECRUITING

Research Site, Glendale

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY